Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Gabapentin NDC 60760-743 by St. Mary's Medical Park Pharmacy, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

GAB - GABAPENTIN 60760 743 90

GAB - GABAPENTIN 60760 743 90

This is a description of Gabapentin, a medication that comes in the form of tablets with a strength of 600mg. It is available in a quantity of 90 tablets per bottle, and each tablet is manufactured by ScienGen Pharmaceuticals, Inc. The medication is prescribed with an RX number and National Drug Code (NDC) for dispensing by pharmacies. The recommended use is as directed by a physician, and it should be stored at a controlled room temperature. The expiration, lot number, and other related details of the medication are also given.*

Figure 1 - image 01

Figure 1 - image 01

The text mentions mean pain score and two types of dosages, work dose titration and fixed dose period, along with a placebo and Gabapentin at 3600 mg/day. The data is also organized in a table with information for baseline and weeks. There is not enough context to determine the purpose or context of the text.*

Figure 2 - image 02

Figure 2 - image 02

This is a graph displaying the mean pain score for different doses of Gabapentin and Placebo over a period of 7 weeks. The dose of Gabapentin is either 1800 or 2400 mg per day. The X-axis represents the weeks of the study, and the Y-axis represents the mean pain score.*

Figure 3 - image 03

Figure 3 - image 03

image-04 - image 04

image-04 - image 04

Gabapentin Structural Formula - image 05

Gabapentin Structural Formula - image 05

Figure 4. Responder Rate in Patients Receiving gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - image 09

Figure 4. Responder Rate in Patients Receiving gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - image 09

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.